Developing novel approaches for cancer gene therapy is one of the division's several basic science research pursuits, while its recent clinical research initiatives have included the compilation of new multi-disciplinary tissue databases tracking patient outcomes in pancreatic and colorectal cancers.
Baylor College of Medicine surgical oncologists emphasize the application of the latest research as quickly and responsibly as possible to the patient under their care giving them access to innovative clinical and therapeutic trials. Our surgeons can offer ground-breaking therapies that target an individual patient’s and their cancer’s unique biology due to their involvement in bench and clinical research, truly bringing research from the bench to the bedside.
Dan L Duncan Comprehensive Cancer Center
At the Dan L Duncan Comprehensive Cancer Center, a National Cancer Institute designated cancer center, we offer the best minds in cancer treatment backed by the renowned researchers at Baylor, improved outcomes through comprehensive, personalized care, and access to the latest clinical trials.
We are at the forefront of personalized medicine, replacing traditional treatments with targeted therapies based on each individual’s unique biology and the exact characteristics of their cancer. The benefits: earlier detection, better prevention, and more effective treatments with fewer side effects.
Elkins Pancreas Center
Researchers at the Elkins Pancreas Center strive to lead the nation in the discovery of effective new treatments for pancreatic cancer. Our robust basic science program has developed several new lines of research this year, attracted $2.3 million dollars in extramural research funding and published our discoveries in over thirty scientific papers in peer-reviewed journals. Many of these discoveries have the potential to be translated into new treatments for our patients by the clinical research team.